VITA — Vitaminka AD Prilep Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapNeutral

Annual cashflow statement for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	—	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	83.2	75.3	109	100	9.93
Depreciation
Non-Cash Items	-22.9	-73.9	16.6	-4.58	—
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-255	-100	10.4	-89.4	-91.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-72.3	28.5	274	153	88.7
Capital Expenditures	-187	-247	-109	-189	-371
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	48.4	88	-51.6	-0.408	-12
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-138	-159	-161	-189	-383
Financing Cash Flow Items	—	27.5	34.8	2.06	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	193	125	-103	49	287
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-17.3	-5.54	9.47	13.3	-7.06